A share price of Pediatrix Medical Group Inc [MD] is currently trading at $11.31, up 2.63%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MD shares have gain 8.65% over the last week, with a monthly amount glided 39.11%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Pediatrix Medical Group Inc [NYSE: MD] stock has seen the most recent analyst activity on June 07, 2024, when Deutsche Bank upgraded its rating to a Hold but kept the price target unchanged to $8 for it. Previously, SVB Leerink started tracking the stock with Mkt Perform rating on September 27, 2021, and set its price target to $29. Deutsche Bank downgraded its rating to a Sell and decreased its price target to $12 on October 19, 2020. Citigroup downgraded its rating to a Neutral but $29 remained the price target by the analyst firm on January 03, 2020. Stifel upgraded its rating to Buy for this stock on December 12, 2019, and upped its price target to $33. In a note dated September 06, 2019, BofA/Merrill downgraded an Underperform rating on this stock.
Pediatrix Medical Group Inc experienced fluctuations in its stock price throughout the past year between $6.62 and $14.82. Currently, Wall Street analysts expect the stock to reach $18.4 within the next 12 months. Pediatrix Medical Group Inc [NYSE: MD] shares were valued at $11.31 at the most recent close of the market. An investor can expect a potential return of 62.69% based on the average MD price forecast.
Analyzing the MD fundamentals
Trailing Twelve Months sales for Pediatrix Medical Group Inc [NYSE:MD] were 2.00B which represents 0.74% growth. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at -0.13%, and Net Profit Margin reading is -0.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.28 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.08 points at the first support level, and at 10.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.48, and for the 2nd resistance point, it is at 11.66.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pediatrix Medical Group Inc [NYSE:MD] is 1.38. Further, the Quick Ratio stands at 1.38, while the Cash Ratio is 0.06. Considering the valuation of this stock, the price to sales ratio is 0.49, the price to book ratio is 1.37.
Transactions by insiders
Recent insider trading involved Richards C Marc, EVP, Chief Financial Officer, that happened on Aug 09 ’24 when 32562.0 shares were sold. EVP, Chief Financial Officer, Richards C Marc completed a deal on Aug 12 ’24 to sell 17438.0 shares. Meanwhile, Former Officer Wood Lee bought 47230.0 shares on Aug 09 ’24.
